Bracco Diagnostics announced that the Food and Drug Administration (FDA) has lifted the contraindication for use of Lumason (sulfur hexafluoride lipid-type A microspheres) in patients with known or ...
Please provide your email address to receive an email when new articles are posted on . Members of the American Society of Echocardiography have backed the use of contrast agents for the enhancement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results